Juan Manuel Sánchez‐Hidalgo

Efficacy and Safety of Intraoperative Hyperthermic Intraperitoneal Chemotherapy for Locally Advanced Colon Cancer

Álvaro Arjona‐Sánchez, Esther Espinosa-Redondo, Alberto Gutiérrez‐Calvo et al. · JAMA Surgery · 2023 · 115 citations · Full text

Medicine, Oncology, Surgery +16

HIPECT4: multicentre, randomized clinical trial to evaluate safety and efficacy of Hyperthermic intra-peritoneal chemotherapy (HIPEC) with Mitomycin C used during surgery for treatment of locally advanced colorectal carcinoma

Álvaro Arjona‐Sánchez, P. Barrios, Emrique Boldo-Roda et al. · BMC Cancer · 2018 · 99 citations · Full text

Medicine, Oncology, Surgery +14

Impact of Donor Graft Steatosis on Overall Outcome and Viral Recurrence After Liver Transplantation for Hepatitis C Virus Cirrhosis

Javier Briceño, Rubén Ciria, M. Pleguezuelo et al. · Liver Transplantation · 2008 · 85 citations · Full text

Medicine, Pathology, Surgery +17

Dysregulated splicing factor SF3B1 unveils a dual therapeutic vulnerability to target pancreatic cancer cells and cancer stem cells with an anti-splicing drug

Emilia Alors‐Pérez, Ricardo Blázquez‐Encinas, Sonia Alcalá et al. · Journal of Experimental & Clinical Cancer Research · 2021 · 58 citations · Full text

Medicine, Cancer Biology, Oncology +17

Peritonectomy procedures and HIPEC in the treatment of peritoneal carcinomatosis from ovarian cancer: Long-term outcomes and perspectives from a high-volume center

Francisco Cristobal Muñoz‐Casares, Francisco Fernández, Álvaro Arjona‐Sánchez et al. · European Journal of Surgical Oncology · 2015 · 56 citations

Medicine, Oncology, Surgery +17